Allan Sylvest Aasberg — CFO
Roles
14.08.2026 – 14.08.2026
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 14.08.2026 | EQL Pharma AB Stockholm | Bought — open marketAcquisition | 20,000 | SEK 26.36 | SEK 527,200.00 | ↗ |